for those interested, my updated Lithium company 'SP' performance comparison SS
regards SY
ps enjoy the rest of your day.
24/05/2021 avg SP % up by 531% avg SP % dwn by -33% Lithium company 'Share Price' Performance Comparison SS ASX Current pos SP (covid low) SP % up from pos Share Price SP % down Code SP # aprx 14mths ago Covid low # 12 mth high from 12mth High CXO 0.235 1 0.013 1708% 10 0.420 -44% EMH 1.215 2 0.130 835% 8 1.920 -37% LTR 0.445 3 0.053 740% 3 0.550 -19% PLS 1.075 4 0.135 696% 5 1.467 -27% SYA 0.032 5 0.006 433% 9 0.056 -43% GLN 0.660 6 0.125 428% 4 0.875 -25% GXY 3.440 7 0.685 402% 2 4.170 -18% AVZ 0.160 8 0.040 300% 6 0.235 -32% VUL 6.630 9 1.830 262% 7 10.000 -34% AGY 0.090 10 0.026 246% 12 0.215 -58% ORE 6.030 11 1.825 230% 1 7.280 -17% LPI 0.205 12 0.105 95% 11 0.390 -47% All lithium stocks are up from their covid lows set aprx 15mths ago now, however the better performers such as CXO, EMH, LTR, PLS, are well and truly out in front of the pack still, in this kpi. My quick observations tell me depending on your risk profile, that it looks as thou there are some buying opp's beginning to present once more, especially when you take into consideration both the rising spod price and future predictions for this commodity going forward, not to mention the fact that most lithium stocks are well off their 12 mth highs at this early stage of evolution to the transition of EV from ICE's, imo This SS is a look back at how some ASX lith stocks have performed over two kpi's only and is not intended to be an indicator of what the future may hold, good luck to all SH's of lith stocks. Note : this is 'current raw data' and does not take into account recent cr, dillution, buy backs, etc, etc aimv
- Forums
- ASX - By Stock
- EMH
- 2021 - The Year for EMH
2021 - The Year for EMH, page-639
-
-
- There are more pages in this discussion • 860 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMH (ASX) to my watchlist
(20min delay)
|
|||||
Last
27.0¢ |
Change
-0.020(6.90%) |
Mkt cap ! $56.01M |
Open | High | Low | Value | Volume |
26.5¢ | 27.0¢ | 26.5¢ | $6.448K | 24.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 34 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 34878 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 34 | 0.270 |
3 | 100111 | 0.265 |
1 | 9214 | 0.260 |
2 | 10639 | 0.255 |
5 | 46574 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 34878 | 1 |
0.305 | 6370 | 1 |
0.310 | 8148 | 1 |
0.325 | 3000 | 1 |
0.330 | 28480 | 4 |
Last trade - 10.05am 15/07/2024 (20 minute delay) ? |
Featured News
EMH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online